Learn more

THE HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC

Overview
  • Total Patents
    59
  • GoodIP Patent Rank
    59,486
About

THE HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC has a total of 59 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia and Singapore. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are HENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC, UNIV JEFFERSON and UNIV DUKE.

Patent filings in countries

World map showing THE HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INCs patent filings in countries
# Country Total Patents
#1 Australia 58
#2 Singapore 1

Patent filings per year

Chart showing THE HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Srivastava Shiv 9
#2 Petrovics Gyorgy 6
#3 Dobi Albert 6
#4 Snapper Clifford M 5
#5 Sun Chen 5
#6 Broder Christopher C 5
#7 Sreenath Taduru 5
#8 Peoples George E 5
#9 Bossart Katharine N 4
#10 Broder Christopher 4

Latest patents

Publication Filing date Title
AU2018213378A1 Vaccine compositions of herpesvirus envelope protein combinations to induce immune response
AU2016334027A1 Biomarkers for diagnosing post traumatic stress disorder
AU2016222467A1 Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
AU2016222452A1 Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
AU2015203572A1 Vaccine for the Prevention of Breast Cancer Recurrence
AU2015209171A1 Antibodies against F glycoprotein of Hendra and Nipah viruses
AU2014362234A1 Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines
AU2014201488A1 Vaccine for the Prevention of Breast Cancer Relapse
AU2014200037A1 Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
AU2013276968A1 Soluble Forms of Hendra and Nipah Virus F Glycoprotein and Uses Thereof
AU2013200151A1 Soluble forms of hendra and nipah virus g glycoprotein
AU2012312805A1 Shigella-derived vector and methods of using the same
AU2011213720A1 Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer
AU2011248517A1 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
AU2010320031A1 (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine
AU2010206800A1 Methods and compositions based on Shiga toxin type 2 protein
AU2008352942A1 Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
AU2008350273A1 HIV-1 envelope glycoprotein oligomer and methods of use
AU2008260399A1 Vaccine for the prevention of breast cancer relapse
AU2005299482A1 Methods for lowering HIF-1 mediated gene expression